The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients

J Cardiovasc Electrophysiol. 1999 Apr;10(4):503-12. doi: 10.1111/j.1540-8167.1999.tb00706.x.

Abstract

Introduction: Catheter ablation may be complicated by clinical thromboembolism in about 1% of patients.

Methods and results: We studied the activation of coagulation (prothrombin fragment 1+2 [PF1+2]), platelets (beta-thromboglobulin [beta-TG])) and fibrinolysis (plasmin-antiplasmin complexes [PAP] and D-dimer) during radiofrequency (RF) ablation in 13 patients. They received heparin 100 U/kg intravenously after the initial electrophysiologic study, prior to the delivery of RF current; thereafter 1,000 U/hour throughout the procedure. PF1+2 increased fourfold (P < 0.001) during the diagnostic study, but gradually declined to upper reference value during heparin administration. There was a strong correlation between procedure duration prior to heparin bolus (range 39 to 173 min); and (a) the maximal rise of PF1+2 (r = 0.83, P < 0.001) and (b) the increase of PF1+2 from baseline to end of the procedure (r = 0.74, P = 0.004). There was no correlation between postheparin changes of PF1+2 and (a) postheparin procedure duration (range 40 to 317 min), (b) number of RF pulses (range 1 to 16), or (c) RF current duration (range 46 to 687 sec). Plasma beta-TG concentration showed similar trends. Fibrinolytic activity increased moderately from baseline until heparin administration; then remained around the upper reference values. PAP at the end of procedure and D-dimer at the time of heparin administration both correlated with preheparin procedure duration (r = 0.70, P = 0.007 and r = 0.69, P = 0.01, respectively). All parameters were normal the next morning.

Conclusion: Procedure duration prior to heparin administration, and not the delivery of RF current per se, determines activation of hemostasis and fibrinolysis during RF ablation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anticoagulants / administration & dosage*
  • Blood Coagulation / physiology*
  • Blood Platelets / physiology
  • Catheter Ablation*
  • Electrocardiography
  • Female
  • Fibrinolysis / physiology*
  • Follow-Up Studies
  • Heparin / administration & dosage*
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Monitoring, Intraoperative
  • Platelet Activation / physiology*
  • Tachycardia, Atrioventricular Nodal Reentry / blood
  • Tachycardia, Atrioventricular Nodal Reentry / complications
  • Tachycardia, Atrioventricular Nodal Reentry / surgery*
  • Thromboembolism / blood
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control
  • Treatment Outcome

Substances

  • Anticoagulants
  • Heparin